Navigation Links
NeurogesX Appoints New Board Director and Audit Committee Chairman
Date:8/25/2009

ng novel pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza, a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions. Qutenza is currently approved in the European Union for the treatment of neuropathic pain in non-diabetic adults, either alone or in combination with other medicinal products for pain. Qutenza will be marketed in the European Union and certain countries in Eastern Europe, the Middle East and Africa, by Astellas Pharma Europe, Ltd. In the United States, NeurogesX submitted a new drug application (NDA) for PHN to the U.S. Food and Drug Administration (FDA) which was accepted for filing by the FDA in December 2008 and has been given an extended Prescription Drug User Fee Act (PDUFA) date of November 16, 2009.

NeurogesX' second most advanced product candidate, NGX-1998, is a topically applied, liquid formulation containing a high concentration of capsaicin designed to treat pain associated with neuropathic pain conditions. NGX-1998 has completed three Phase 1 studies and NeurogesX is currently planning the design and timing of this program.

NeurogesX' early stage product pipeline includes pre-clinical compounds, which are prodrugs of acetaminophen and various opioids. The company has evaluated these compounds in vitro and in vivo and is currently seeking development partners for these programs.

Safe Harbor Statement

This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the "Act"). NeurogesX disclaims any intent or obligation to update these forward-looking statements, and claims the protection
'/>"/>

SOURCE NeurogesX
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. NeurogesX Reports Second Quarter 2009 Results
2. NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application
3. NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results
4. NeurogesX Added to Russell 3000 Index
5. NeurogesX Provides U.S. Regulatory Update for Qutenza(TM)
6. NeurogesX to Present at Needham Life Sciences Conference
7. NeurogesX Receives European Commission Approval for Qutenza(TM)
8. NeurogesX Reports First Quarter 2009 Results
9. NeurogesX to Hold Conference Call to Discuss First Quarter 2009 Financial Results
10. NeurogesX Presents Two Posters at 61st Annual American Academy of Neurology Annual Meeting
11. NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Year-End 2008 Financial Results and European Regulatory Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2014)... 18, 2014  Neogen Corporation (Nasdaq: NEOG ... chief operating officer and president, has resigned, effective July ... a consultant going forward on special projects. His resignation ... in this position since September 2013. On an interim ... Herbert , who has been Neogen,s chief executive officer ...
(Date:7/18/2014)... (PRWEB) July 18, 2014 Reflecting the importance ... past ten years, Connie Rankin, the founder and president ... affiliate, recently introduced a fresh new approach to the ... for a Broker to influence the success of his or ... years. CRES was one of the first in this market ...
(Date:7/18/2014)... Nuclear Power Countries - Market Forecast, Key Companies and ... report from GlobalData, Emerging Nuclear Power Countries - Market ... the emerging nuclear market and the key factors affecting ... players and their global market share. The market value ... has also been estimated. , To browse a full ...
(Date:7/18/2014)... Switzerland , July 18, 2014 ... Education in Animal Research for the third consecutive year. ... State University, will attend a 1-week course at Zürich ... of the 3Rs (Replace, Reduce, Refine). As head of ... Popov has been given the task of adapting experimental ...
Breaking Biology Technology:LEED AP Certified ITRA Global / Customized Real Estate Services Introduces New Approach to Its Branding 2Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 2Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 3Young Moscovite Researcher Receives this Year's "Basel Declaration Award for Education in Animal Research" 2
... /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex:,SVA), a vaccine-focused ... Yin, Chairman, President and CEO, is scheduled to ... Management Summit,Conference, at Grant Hyatt Beijing Hotel in ... 11th at 1:35 p.m., About Sinovac, ...
... realize the electrical units of voltage, resistance and ... are nowadays used. Important prerequisites are extremely pure ... crystal without collision with residual impurities. To be ... has set up a new molecular beam epitaxy ...
... for Anticipated VentriPoint Diagnostic System Launch, Alpha ... SEATTLE, Aug. 29 VentriPoint Diagnostics,(TSX: VPT) ... discussion and,analysis (MD&A), as well as its unaudited ... 2008, with the Canadian Securities Administrators,through the SEDAR ...
Cached Biology Technology:Sinovac to Present at the Susquehanna Financial Group's Second Annual Beijing Management Summit Conference 2'Racetrack' for fast electrons in semiconductor structures 2VentriPoint Diagnostics Files Management Discussion and Analysis, Unaudited Financial Results for 2Q 2008 2
(Date:7/21/2014)... seriousness of disease often results from the strength of ... down that response, rather than attacking the virus, might ... Juliet Morrison of the University of Washington, Seattle. She ... in doing just that for the H7N9 influenza, and ... potential therapeutics for this highly virulent strain. The research ...
(Date:7/21/2014)... between songbird species, investigators have found that migration routes ... The research, which is published in Ecology Letters ... the position of a bird and allow its long ... parents, hybrids exhibited increased variability in their migratory routes: ... others used the same routes as one parental group ...
(Date:7/21/2014)... traditional apple orchards, effective management practices rely ... manage competitive vegetation under the trees, and ... factors are further complicated in organic management ... producers need to meet the stringent soil ... the National Organic Program. University of Arkansas ...
Breaking Biology News(10 mins):Potential new flu drugs target immune response, not virus 2Organic apple orchards benefit from green compost applications 2
... American Dietetic Association has published an updated position paper ... calls on schools and communities to work together to ... to promote educational environments that help students learn and ... updated position paper, published in the August issue of ...
... have identified a genetic variant which increases susceptibility to ... as a genome-wide association (GWA) study. This is the ... technique in Africans and demonstrates that such studies are ... of genetic diversity. Over the past few years, ...
... Providing patients with chronic heart failure access to remote ... technology, reduces deaths and hospitalisations and may provide benefits ... are the conclusions of a new Cochrane Systematic Review ... of patients can reduce pressure on resources, particularly for ...
Cached Biology News:Schools, communities share responsibility for child nutrition 2Schools, communities share responsibility for child nutrition 3Genome study identifies genetic variant linked to TB susceptibility in Africans 2Genome study identifies genetic variant linked to TB susceptibility in Africans 3Health care using telephone and telemonitoring technology benefits heart failure patients 2
... The thermostable dUTPase(pyrococcus fruriosus) maximizes the ... DNA polymerases). It removes contaminating ... dNTP solutions. The presence of ... reaction can prevent dUTP misincorporation by ...
... comes with a shutter (controlled via a TTL ... Deuterium Light Source produces a powerful, stable output ... the light source are available, providing a wavelength ... lamp provides peak-to-peak stability of less than 0.005% ...
... The NOVOstar is an exciting product for ... cell-based assays required the use of expensive ... for scientists in the assay development stage. ... for cell-based assays as well as any ...
... intactness and detects events that dissipate ... Benefits: Fast, simple, and ... and for assaying mitochondria intactness ... for the detection of changes in ...
Biology Products: